Fungal Infection Diagnosis Market

Invasive candidiasis is an infection caused by a yeast (a type of fungus) called Candida. Unlike Candida infections in the mouth and throat (also called ?thrush?) or vaginal ?yeast infections,? invasive candidiasis is a serious infection that can affect the blood, heart, brain, eyes, bones, and other parts of the body. Candidemia, a bloodstream infection with Candida, is a common infection in hospitalized patients
At present, most hospitals are carrying out non-invasive laboratory diagnosis techniques such as G test and GM test.
Fungal Infection Diagnosis Market contains market size and forecasts of Fungal Infection Diagnosis in Global, including the following market information:
Global Fungal Infection Diagnosis Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Fungal Infection Diagnosis market was valued at 19 million in 2021 and is projected to reach US$ 30 million by 2028, at a CAGR of 7.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Galactomannan Test Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Fungal Infection Diagnosis include ASSOCIATES OF CAPE COD, BioRad, IMMY, Beijing Jinshanchuan, Danna Biological and Zhanjiang A & C Biological Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Fungal Infection Diagnosis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fungal Infection Diagnosis Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Fungal Infection Diagnosis Market Segment Percentages, by Type, 2021 (%)
Galactomannan Test
(1 to 3)-?-D-glucan Experiment
Global Fungal Infection Diagnosis Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Fungal Infection Diagnosis Market Segment Percentages, by Application, 2021 (%)
Hospital
Laboratory
Others
Global Fungal Infection Diagnosis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Fungal Infection Diagnosis Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Fungal Infection Diagnosis revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Fungal Infection Diagnosis revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
ASSOCIATES OF CAPE COD
BioRad
IMMY
Beijing Jinshanchuan
Danna Biological
Zhanjiang A & C Biological Ltd.